What it isFirst-generation antipsychotic structurally related to clozapine; schizophrenia, and inhaled for acute agitation.
Why this oneThe inhaled form acts within ten minutes without an injection.
What limits itInhalation can cause bronchospasm and requires a REMS with spirometry. Extrapyramidal effects; its metabolite amoxapine is an antidepressant.
BOXED WARNING Increased mortality in elderly patients with dementia-related psychosis treated with antipsychotics; not approved for dementia-related psychosis.
FDA dosing
Population
Start
Target
Max
Schizophrenia
Adults
10 mg BID
60–100 mg/day (divided BID–QID)
250 mg/day
Renal Undefined
Hepatic Undefined
Instructions
Administer in divided doses 2–4 times daily.
Increase fairly rapidly over the first 7–10 days to symptom control.
Maintenance: reduce to lowest effective dose (often 20–60 mg/day).
Contraindications
Comatose or severe drug-induced CNS depression (alcohol, barbiturates, narcotics)